Effects of 4-aminopyridine on cardiac repolarization, PR interval, and heart rate in patients with spinal cord injury

Pharmacotherapy

Volumn 23, Issue 2, 2003, Pages 133-136

  Isoda, Wakana C ^a,b   Segal, Jack L ^b  

^a TOYOTA MOTOR CORPORATION   (Japan)

^b HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOPYRIDINE;

ADULT; ARTICLE; CLINICAL TRIAL; COMPUTER ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG FORMULATION; DRUG RELEASE; DRUG SAFETY; ELECTROCARDIOGRAM; FEMALE; HEART ARRHYTHMIA; HEART RATE; HEART REPOLARIZATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PARAPLEGIA; PR INTERVAL; QT INTERVAL; QUADRIPLEGIA; RANDOMIZED CONTROLLED TRIAL; SEX; SINGLE BLIND PROCEDURE; SPINAL CORD INJURY; TITRIMETRY;

4-AMINOPYRIDINE; ADULT; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FEMALE; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; MALE; MIDDLE AGED; PARAPLEGIA; POTASSIUM CHANNEL BLOCKERS; QUADRIPLEGIA; SPINAL CORD INJURIES;

EID: 0037322273     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.23.2.133.32089     Document Type: Article

References (9)

1. Segal JL, Pathak MS. Optimal drug therapy and therapeutic drug monitoring after spinal cord injury: a population-specific approach. Am J Ther 2001;8:451-63.
2. Bunge RP, Puckett WR, Bercerra JL, Marcillo A, Quencer RM. Observations on the pathology of human spinal cord injury: a review and classification of 22 new cases with details from a case of chronic cord compression with extensive local demyelination. In: Seil FJ, ed. Advances in neurology, vol. 59. New York: Raven Press, 1993:75-89.
3. Bunten DC, Warner AL, Brunnemann SR, Segal JL. Heart rate variability is altered following spinal cord injury. Clin Auton Res 1998;8:329-34.
4. Segal JL, Pathak MS, Hernandez JP, Himber PL, Brunnemann SR, Charter RS. Safety and efficacy of 4-aminopyridine in humans with spinal cord injury: a long-term, controlled trial. Pharmacotherapy 1999;19:713-23.
5. Bonate PL. Rank power of metrics used to assess QTc interval prolongation by clinical trial simulation. J Clin Pharmacol 2000;40:468-74.
6. Bonate PL, Russell T. Assessment of QTc prolongation for noncardiac-related drugs from a drug development perspective. J Clin Pharmacol 1999;39:349-58.
7. Khoshoo V, Edell D, Clarke R. Effect of cisapride on the QT interval in infants with gastroesophageal reflux [online exclusive article]. Pediatrics 2000;105:e24. Available from www.pediatrics.org/cgi/content/full/105/2/e24. Accessed December 2002.
8. American Spinal Cord Injury Association-International Medical Society of Paraplegia. International standards for neurological and functional classification of spinal cord injury, 4th ed. Chicago: American Spinal Cord Injury Association, 1996.
9. Lentner C. Geigy scientific tables: heart and circulation, vol. 5. Basel: Ciba-Geigy Limited, 1990;10:156-8.